Global biotechnology company Alvotech (NASDAQ: ALVO), which develops and manufactures biosimilar medicines, said on Monday it has signed supply and commercialisation agreements w...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
2 February 2026 -
2 February 2026 - Cell-free DNA testing company Natera Inc (NASDAQ: NTRA) said on Monday that it has submitted a premarket approval application to the US Food and Drug Administration (FDA) for Signatera CDx to detect molecular residual disease (MRD) ...
2 February 2026 - Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) revealed on Monday that the US Food and Drug Administration (FDA) has issued a Complete Response Letter for its supplemental New Drug Application...
2 February 2026 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (NYSE: AZN) reported on Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Imfinzi (durvalumab)...
2 February 2026 - I Peace Inc, a California-based GMP cell therapy CDMO, announced on Friday that it has generated human induced pluripotent stem (iPS) cells from NKT cells and has started offering them for research use.NKT cells are immune cells kno...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe